Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2023 Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Medicenna Therapeutics Corp. (NASDAQ:MDNA) Q2 2023 Earnings Conference Call November 4, 2022 8:30 AM ET

Company Participants

Dan Ferry - IR, LifeSci Advisors

Fahar Merchant - President & CEO

Liz Williams - CFO

Conference Call Participants

David Martin - Bloom Burton

Catherine Novack - Jones Search


Hello and welcome to the Medicenna Therapeutics' Fiscal Second Quarter Earnings Call. All participants are in a listen-only mode. There will be a Q&A session at the end of the prepared remarks. Please be advised this call is being recorded at the company's request.

I would now like to turn the call over Dan Ferry of LifeSci Advisors. Please go ahead.

Dan Ferry

Thank you, operator and thank you all for participating in today's conference call. This morning, Medicenna issued a press release providing financial results and corporate updates for the quarter ended September 30th, 2022. If you have not yet seen the press release, it is available on the Investors page of Medicenna’s website.

Before we begin, I would like to remind you that certain statements and information shared during this call, constitute forward-looking information within the meaning of applicable securities laws. All statements other than statements of historical facts shared during this call and that relate to the future operations of the company, and other statements that are not historical facts, including statements related to the clinical potential and development of MDNA11, preliminary clinical data, cash runway, the presentation of additional data, and other milestones are forward-looking statements that are subject to risks and uncertainties. There could be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

Important factors that could cause actual results to differ materially from the company's expectations, include the risks detailed in

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.